Startups

GeNeuro is a clinical stage pharmaceutical company developing a new approach to the treatment of autoimmune diseases.

Summary

Seedtable Score
  • 4
Locations
Company Size
  • 11 to 50 employees
Last Stage Round

Total funding Amount

$42M

Fundraising History

Investors